Bedal International has announced the successful closure of an $11m funding round aimed at bolstering the global growth of its FlexGRIP catheter securement devices.
The investment is set to enhance the company’s operations and commercial efforts, particularly in the US market.
The funding round was spearheaded by Belgian venture capitalist fund White Fund and Belgium’s Sovereign Wealth Fund, SFPIM.
Related: Neuromod developer Neuspera Medical raises $23M in Series D
It also saw participation from US-based medtech investors and Bedal’s existing backers, F3Finance and LRM. The Bedal management team also participated in the round.
White Fund official Eric Brandt said: “White Fund and SFPIM are excited to support Bedal’s mission to improve patient care through its innovative devices.”
SFPIM CIO Céline Vaessen said: “We believe in Bedal’s potential to become the golden standard for catheter care. We are proud to be part of their promising growth journey and are committed to supporting their product development engine with the ambition of making a profound impact on the lives of patients and caregivers.”
Designed to safely secure catheters, FlexGRIP devices are currently utilised in more than 34 countries. They have been instrumental in reducing complications and enhancing patient outcomes.
Bedal has also secured global agreements with several catheter companies.
Bedal International CEO Alexander Van Damme said: “Since we founded Bedal, it has already been an incredible journey from launching the devices to growing into a global footprint.
“This new funding marks the beginning of a next chapter for us, focused on setting a new standard in the market.”
Bedal’s FlexGRIP products are designed to enhance catheter stabilisation while reducing the risk of dislodgement, infection, and kinking.
